AstraZeneca Covid vaccine sales hit $275 mn in first quarter
Kort samengevat
British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face of EU legal action.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Medical Xpress.
Lees het volledige bericht ↗